Summary & Overview
CPT 81599: Multianalyte Assay with Algorithmic Analysis
CPT code 81599 denotes a multianalyte assay with algorithmic analysis (MAAA) when no specific Category I code or Appendix O administrative code exists. Nationally, this code is important for reporting complex, algorithm-driven laboratory tests used in diagnostics, prognostics, and therapeutic decision support across clinical specialties. Its use affects billing, coverage determinations, and visibility of advanced laboratory services.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how 81599 is applied, payer coverage considerations, and typical sites of service for MAAA testing. The publication summarizes common modifiers associated with laboratory and professional billing, and describes the implications of using an unlisted multianalyte code when no specific code exists.
The report provides benchmarks and policy context relevant to payers and providers, including coding practice, documentation expectations, and references to administrative coding guidance. It also outlines what clinicians and billing staff should document when ordering or submitting claims for MAAA testing and highlights areas where payers commonly request additional clinical or technical information. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 81599 is used to report a multianalyte assay with algorithmic analysis (MAAA) that does not have a specific Category I code or an administrative code in Appendix O. This code captures complex laboratory tests that combine multiple analyte measurements with a proprietary algorithm to generate a clinical interpretation or risk score.
Service type: Laboratory — multianalyte assay with algorithmic analysis
Typical site of service: Clinical laboratory or reference laboratory; testing may be ordered in outpatient, inpatient, or other care settings where specimens are collected and sent to a laboratory for complex molecular or biochemical analysis.
Clinical & Coding Specifications
Clinical Context
A patient presents to an outpatient clinical laboratory or an oncology clinic for a specialized blood-based multianalyte assay with algorithmic analysis (MAAA) to aid in diagnosis, prognosis, or therapeutic decision-making. Typical patients include those with suspected or confirmed cancer, complex metabolic or genetic conditions, or conditions where integration of multiple biomarkers into an algorithm informs risk stratification or treatment selection. The clinician orders the MAAA when single-analyte testing is insufficient and when an FDA-cleared or laboratory-developed algorithmic panel specific to the clinical question is not captured by a Category I CPT code or Appendix O administrative code.
In workflow, the clinician places the order in the electronic health record specifying specimen type (usually blood/serum/plasma), relevant clinical indication, and required billing information. Phlebotomy is performed at an outpatient laboratory, hospital outpatient department, or an oncology infusion center. The specimen is processed and sent to the performing laboratory where analytical measurement of multiple biomarkers is run, followed by application of the validated algorithm to generate a composite result or risk score. Results are reported to the ordering clinician with interpretation to guide management. Billing uses 81599 to report the MAAA when no specific Category I code exists; appropriate diagnosis codes accompany the claim to justify medical necessity.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|